Global Implantable Cardioverter Defibrillator (ICD) Market Size, Share, Opportunities, And Trend By Chamber (Single Chambered, Dual Chambered), By Type (Subcutaneous ICD, Transvenous ICD, Cardiac Resynchronization Therapy Defibrillator), By End-User (Hospitals & Clinics, Ambulatory Care Centre), And By Geography - Forecasts From 2025 To 2030

The global implantable cardioverter defibrillators market will grow at a CAGR of 6.00% to be valued at US$6.868 billion in 2030 from US$5.131 billion in 2025.

An implantable cardioverter defibrillator is an implantable electronic device that is used for treatment in case of sudden cardiac arrest and arrhythmia. The device can be used to detect an abnormal heart rate and to deliver electric shocks if required to the patients. The rapidly increasing geriatric population in many regions across the globe is a major factor responsible for the growth of the implantable cardioverter defibrillators market. According to Forbes, 2019, the number of individuals 65 years and older increased by 33%, from 37.2 to 49.2 million people between 2007 to 2017. The number is further expected to continue rising, doubling to 98 million by 2060. Further, the 85 years and older population are expected to increase by more than 8 million by 2040, which will drive market growth as more patients will require implantable cardioverter defibrillators for their treatment.

Growing Incidence of Cardiac Arrests Drives Demand for Implantable Cardioverter Defibrillators

The increasing prevalence of sudden cardiac arrests, often triggered by ventricular arrhythmia or other causes, is fueling demand for advanced implantable cardioverter defibrillators (ICDs). These devices monitor a patient's heartbeat and restore normal rhythm when abnormalities are detected. For example, the British Heart Foundation reported in 2019 that the United Kingdom sees over 30,000 out-of-hospital cardiac arrests annually, with emergency services attempting resuscitation. ICDs play a critical role in such scenarios, potentially saving lives and reducing mortality rates.

Technological Advancements Enhance Adoption

Ongoing technological improvements are enhancing the efficiency and reliability of implantable cardioverter defibrillators, driving their adoption among end-users. These advancements are expected to further strengthen demand for ICDs throughout the forecast period, as healthcare providers and patients increasingly rely on these life-saving devices.Some of the major players covered in this report include Medtronic Plc., Abbott Laboratories, Boston Scientific Corporation, Biotronik SE & Co. KG, MicroPort Scientific Corporation, among others.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2022 to 2024 & forecast data from 2025 to 2030
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

Implantable Cardioverter Defibrillator (ICD) Market Segmentations:

Implantable Cardioverter Defibrillator (ICD) Market Segmentation by product type

The report analyzes the market by product type as below:

• Single-Chamber ICDs
• Dual-Chamber ICDs
• Biventricular ICDs (CRT-D)

Implantable Cardioverter Defibrillator (ICD) Market Segmentation by procedure

The report analyzes the market by procedure as below:

• Transvenous Implantable Cardioverter Defibrillators (TV-ICDs)
• Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs)

Implantable Cardioverter Defibrillator (ICD) Market Segmentation by application

The report analyzes the market by application as below:

• Arrhythmia Management
• Heart Failure
• Other Applications

Implantable Cardioverter Defibrillator (ICD) Market Segmentation by end user

The report analyzes the market by end-user as below:

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers (ASCs)

Implantable Cardioverter Defibrillator (ICD) Market Segmentation by regions:

The study also analysed the implantable cardioverter defibrillator (ICD) market into the following regions, with country level forecasts and analysis as below:

• North America (USA, Canada and Mexico)
• South America (Brazil, Argentina, and Others)
• Europe (Germany, UK, France, Spain, and Others
• Middle East and Africa (Saudi Arabia, UAE, and Others)
• Asia Pacific (China, Japan, India, South Korea, Thailand, Indonesia, and Others)

Implantable Cardioverter Defibrillator (ICD) Market Report Coverage:

This report provides extensive coverage as explained in the points below:

• Market size, forecasts, and trends by different product type, with historical revenue data and analysis focusing on key factors driving adoption, current challenges faced by key players, and major growth areas.
• Market size, forecasts, and trends by procedure, with historical revenue data and analysis.
• Market size, forecasts, and trends by application, with historical revenue data and analysis.
• Market size, forecasts, and trends by end-user, with historical revenue data and analysis across various segments.
• The implantable cardioverter defibrillator (ICD) market is also analysed across different regions, with historical data, regional share, attractiveness and opportunity of these solutions in different countries. The growth prospects and key players operating in these markets. The section also dwells on the macro factors, economic scenario and other complementing factors aiding in market growth.
• Market dynamics: The section details the market growth factors, restraints, and opportunities in the market. The segment also presents complete market scenario with the help of Porter's five forces model.
• Competitive Intelligence: A thorough investigation on the competitive structure of the market presented through proprietary vendor matrix model, market share analysis of key players, insights on strategies of key players and recent major developments undertaken by the companies to gain competitive edge.
• Research methodology: The assumptions and sources which were considered to arrive at the final market estimates. Additionally, how our model is refined to ensure most significant factors are taken into consideration with the proper hypothesis and bottom-up and top-down approaches enhance the reliability of forecasts further strengthening the trustworthiness of the numbers being presented.

How this report is helpful to you and reasons for purchase?

• The report provides a strategic outlook of the implantable cardioverter defibrillator (ICD) market to the decision-makers, analysts and other stakeholders in the easy to read format for taking informed decisions.
• The charts, tables and figures make it easy for the executives to gain valuable insights while skimming the report.
• Analyst support through calls and email for timely clarification and incorporating additional requests.
• Option of presentation or doc format with the estimates file to take care of diverse requirements.
• 15% FREE customization with all our reports help cater additional requirements with significant cost-savings.
• Option of purchasing specific segments of the study, including opting for summary reports or just the estimates file.

---

1. EXECUTIVE SUMMARY 

2. MARKET SNAPSHOT

2.1. Market Overview

2.2. Market Definition

2.3. Scope of the Study

2.4. Market Segmentation

3. BUSINESS LANDSCAPE 

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities 

3.4. Porter’s Five Forces Analysis

3.5. Industry Value Chain Analysis

3.6. Policies and Regulations 

3.7. Strategic Recommendations 

4. TECHNOLOGICAL OUTLOOK

5. IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) MARKET BY PRODUCT TYPE

5.1. Introduction

5.2. Single-Chamber ICDs

5.3. Dual-Chamber ICDs

5.4. Biventricular ICDs (CRT-D)

6. IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) MARKET BY PROCEDURE 

6.1. Introduction

6.2. Transvenous Implantable Cardioverter Defibrillators (TV-ICDs)

6.3. Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs)

7. IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) MARKET BY APPLICATION

7.1. Introduction

7.2. Arrhythmia Management

7.3. Heart Failure

7.4. Other Applications

8. IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) MARKET BY END-USER

8.1. Introduction

8.2. Hospitals

8.3. Specialty Clinics

8.4. Ambulatory Surgical Centers (ASCs)

9. MAGNETIC RESONANCE IMAGING SYSTEMS MARKET BY GEOGRAPHY

9.1. Introduction

9.2. North America

9.2.1. USA

9.2.2. Canada

9.2.3. Mexico

9.3. South America

9.3.1. Brazil

9.3.2. Argentina

9.3.3. Others

9.4. Europe

9.4.1. United Kingdom

9.4.2. Germany

9.4.3. France

9.4.4. Italy

9.4.5. Spain

9.4.6. Others

9.5. Middle East and Africa

9.5.1. Saudi Arabia

9.5.2. UAE

9.5.3. Others

9.6. Asia Pacific

9.6.1. China

9.6.2. Japan

9.6.3. India

9.6.4. South Korea

9.6.5. Taiwan

9.6.6. Thailand

9.6.7. Indonesia

9.6.8. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

10.1. Major Players and Strategy Analysis

10.2. Market Share Analysis

10.3. Mergers, Acquisitions, Agreements, and Collaborations

10.4. Competitive Dashboard

11. COMPANY PROFILES

11.1. Medtronic Plc.

11.2. Abbott Laboratories

11.3. Boston Scientific Corporation

11.4. Biotronik SE & Co. KG

11.5. MicroPort Scientific Corporation

11.6. LivaNova PLC 

11.7. Koninklijke Philips N.V. 

11.8. Zoll Medical Corporation 

11.9. Cardiac Science Corporation 

11.10. Nihon Kohden Corporation

12. APPENDIX

12.1. Currency 

12.2. Assumptions

12.3. Base and Forecast Years Timeline

12.4. Key benefits for the stakeholders

12.5. Research Methodology 

12.6. Abbreviations 

Medtronic Plc.

Abbott Laboratories

Boston Scientific Corporation

Biotronik SE & Co. KG

MicroPort Scientific Corporation

LivaNova PLC 

Koninklijke Philips N.V. 

Zoll Medical Corporation 

Cardiac Science Corporation 

Nihon Kohden Corporation

Medtronic Plc.

Abbott Laboratories

Boston Scientific Corporation

Biotronik SE & Co. KG

MicroPort Scientific Corporation

LivaNova PLC 

Koninklijke Philips N.V. 

Zoll Medical Corporation 

Cardiac Science Corporation 

Nihon Kohden Corporation